Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons.
Front Immunol. 2021 Mar 30;12:658753. doi: 10.3389/fimmu.2021.658753. eCollection 2021.
Front Immunol. 2021.
PMID: 33859650
Free PMC article.
Review.